[go: up one dir, main page]

PL367343A1 - Zastosowanie LH w kontrolowanej hiperstymulacji jajeczkowania - Google Patents

Zastosowanie LH w kontrolowanej hiperstymulacji jajeczkowania

Info

Publication number
PL367343A1
PL367343A1 PL02367343A PL36734302A PL367343A1 PL 367343 A1 PL367343 A1 PL 367343A1 PL 02367343 A PL02367343 A PL 02367343A PL 36734302 A PL36734302 A PL 36734302A PL 367343 A1 PL367343 A1 PL 367343A1
Authority
PL
Poland
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
PL02367343A
Other languages
English (en)
Other versions
PL205472B1 (pl
Inventor
Stephen Hillier
Colin Michael Howles
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL367343(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of PL367343A1 publication Critical patent/PL367343A1/pl
Publication of PL205472B1 publication Critical patent/PL205472B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL367343A 2001-09-12 2002-09-12 Zastosowanie hormonu luteinizującego (LH) PL205472B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12

Publications (2)

Publication Number Publication Date
PL367343A1 true PL367343A1 (pl) 2005-02-21
PL205472B1 PL205472B1 (pl) 2010-04-30

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
PL367343A PL205472B1 (pl) 2001-09-12 2002-09-12 Zastosowanie hormonu luteinizującego (LH)

Country Status (27)

Country Link
US (1) US7341989B2 (pl)
EP (1) EP1434600B1 (pl)
JP (1) JP2005504072A (pl)
KR (1) KR20040032953A (pl)
CN (1) CN1302806C (pl)
AR (1) AR036591A1 (pl)
AT (1) ATE427755T1 (pl)
AU (1) AU2002331939B2 (pl)
BR (1) BR0212502A (pl)
CA (1) CA2457067A1 (pl)
CY (1) CY1110487T1 (pl)
DE (1) DE60231892D1 (pl)
DK (1) DK1434600T3 (pl)
EA (1) EA009210B1 (pl)
ES (1) ES2322136T3 (pl)
HR (1) HRP20040070A2 (pl)
IL (1) IL160781A0 (pl)
ME (1) MEP38808A (pl)
MX (1) MXPA04002125A (pl)
NO (1) NO327154B1 (pl)
PL (1) PL205472B1 (pl)
PT (1) PT1434600E (pl)
RS (1) RS51505B (pl)
SI (1) SI1434600T1 (pl)
UA (1) UA78970C2 (pl)
WO (1) WO2003022301A2 (pl)
ZA (1) ZA200401008B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04012246A (es) * 2002-06-07 2005-04-08 Ares Trading Sa Metodo para la hiperestimulacion ovarica controlada y equipo farmaceutico para usarlo en dicho metodo.
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
PT1176976E (pt) * 1999-05-07 2006-11-30 Applied Research Systems Utilização de lh administrada na fase folicular média e tardia para o tratamento de mulheres anovulatórias.

Also Published As

Publication number Publication date
WO2003022301A2 (en) 2003-03-20
EP1434600A2 (en) 2004-07-07
AR036591A1 (es) 2004-09-22
KR20040032953A (ko) 2004-04-17
ZA200401008B (en) 2005-08-31
HK1067866A1 (en) 2005-04-22
NO20040990L (no) 2004-03-08
US7341989B2 (en) 2008-03-11
EA009210B1 (ru) 2007-12-28
HRP20040070A2 (en) 2004-10-31
EP1434600B1 (en) 2009-04-08
CN1553809A (zh) 2004-12-08
EA200400428A1 (ru) 2004-08-26
WO2003022301A3 (en) 2003-04-17
CA2457067A1 (en) 2003-03-20
ES2322136T3 (es) 2009-06-17
MEP38808A (en) 2011-02-10
DE60231892D1 (de) 2009-05-20
ATE427755T1 (de) 2009-04-15
IL160781A0 (en) 2004-08-31
YU21204A (sh) 2006-08-17
RS51505B (sr) 2011-06-30
US20050049199A1 (en) 2005-03-03
MXPA04002125A (es) 2004-07-08
CY1110487T1 (el) 2015-04-29
PT1434600E (pt) 2009-04-28
SI1434600T1 (sl) 2009-06-30
JP2005504072A (ja) 2005-02-10
DK1434600T3 (da) 2009-05-25
PL205472B1 (pl) 2010-04-30
AU2002331939B2 (en) 2007-10-25
BR0212502A (pt) 2004-08-24
UA78970C2 (uk) 2007-05-10
CN1302806C (zh) 2007-03-07
NO327154B1 (no) 2009-05-04

Similar Documents

Publication Publication Date Title
HRP20040087A2 (en) USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
PL370480A1 (pl) Aminopirymidyny i aminopirydyny
HRP20031000A2 (en) Benzoylsulfonamides and sulfonylbenzamidines as antitumour agents
PL369855A1 (pl) 4-arylochinazoliny i ich zastosowanie jako inhibitorów NHE-3
PL372888A1 (pl) Modyfikowane i stabilizowane propeptydy GDF i ichzastosowanie
GB0124730D0 (en) Improvements in or relating to devices
IL154553A0 (en) Urocortin-iii and uses thereof
GB0116965D0 (en) Cosmetic devices
PL367343A1 (pl) Zastosowanie LH w kontrolowanej hiperstymulacji jajeczkowania
SI1425033T1 (sl) Uporaba hcg in lh pri kontrolirani ovarijski hiperstimulaciji
GB2376928B (en) Personal hoverplane having four tiltmotors
EP1353581A4 (en) BACKPACK
GB2387737B (en) Improvements in or relating to telephone communications control devices
GB0125287D0 (en) Controlling garment size
GB0125859D0 (en) Hand/wrist saving device
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0219108D0 (en) Controlling electronic devices
GB0122316D0 (en) Threaded article
TW493609U (en) Moving and carrying device
GB2407736B (en) Improvements in or relating to telephone communications control devices
TW483458U (en) Anti-leaking block structure
CA93687S (en) Rucksack
GB2381908A8 (en) Integrated vertical-horizontal multi-portal
TW475721U (en) Anti-robbing holster structure
CA92972S (en) Backpack